Quarterly Result
| Goldline Pharmaceutical Ltd Industry: (Trading) |
|---|
|
BSE Code:
544759
ISIN Demat:
INE1CLW01015
Book Value(₹): 25.05 NSE Symbol: N.A Div & Yield(%):
N.A
Market Cap(₹ Cr): 39.33 P/E(TTM): N.A
EPS(TTM): N.A
Face Value(₹): 10.00 |
| Particulars | Mar 2026 (₹ Cr) | Dec 2025 (₹ Cr) |
|---|---|---|
| Gross Sales | 9.79 | 7.51 |
| Excise Duty | 0.00 | 0.00 |
| Net Sales | 9.79 | 7.51 |
| Other Operating Income | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 |
| Total Income | 9.79 | 7.52 |
| Total Expenditure | 7.01 | 5.99 |
| PBIDT | 2.78 | 1.52 |
| Interest | 0.35 | 0.30 |
| PBDT | 2.44 | 1.22 |
| Depreciation | 0.06 | 0.06 |
| Tax | 0.68 | 0.29 |
| Fringe Benefit Tax | 0.00 | 0.00 |
| Deferred Tax | -0.20 | 0.00 |
| Reported Profit After Tax | 1.89 | 0.87 |
| Extra-ordinary Items | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.89 | 0.87 |
| EPS (Unit Curr.) | 2.18 | 1.00 |
| EPS (Adj) (Unit Curr.) | 2.18 | 1.00 |
| Calculated EPS (Unit Curr.) | 2.18 | 1.00 |
| Calculated EPS (Adj) (Unit Curr.) | 2.18 | 1.00 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.70 | 3.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.70 | 3.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 |
| Equity | 8.71 | 8.71 |
| Reserve & Surplus | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 |
| PBIDTM(%) | 28.40 | 20.24 |
| PBDTM(%) | 24.92 | 16.25 |
| PATM(%) | 19.31 | 11.58 |